JB Chemicals & Pharmaceuticals has completed the acquisition of a portfolio of brands for the India market from Sanzyme (Sanzyme), a leading player in the probiotics and reproductive health segment in the country. The company has acquired portfolio of brands, for use and commercialization within India.The acquisition will mark company’s entry into the fast-growing probiotics, therapeutic nutraceuticals and reproductive health market with attractive set of brands.
JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).
